SRX5492836 GSM3660254 GSM3660254: Patients plasma exosomal miRNA [N1]; Homo sapiens; miRNA-Seq SRP187871 SRS4462704 GSM3660254 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660254 GEO Accession GSM3660254 SRX5492837 GSM3660255 GSM3660255: Patients plasma exosomal miRNA [N2]; Homo sapiens; miRNA-Seq SRP187871 SRS4462705 GSM3660255 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660255 GEO Accession GSM3660255 SRX5492838 GSM3660256 GSM3660256: Patients plasma exosomal miRNA [N3]; Homo sapiens; miRNA-Seq SRP187871 SRS4462706 GSM3660256 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660256 GEO Accession GSM3660256 SRX5492839 GSM3660257 GSM3660257: Patients plasma exosomal miRNA [N4]; Homo sapiens; miRNA-Seq SRP187871 SRS4462707 GSM3660257 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660257 GEO Accession GSM3660257 SRX5492840 GSM3660258 GSM3660258: Patients plasma exosomal miRNA [N5]; Homo sapiens; miRNA-Seq SRP187871 SRS4462708 GSM3660258 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660258 GEO Accession GSM3660258 SRX5492841 GSM3660259 GSM3660259: Patients plasma exosomal miRNA [N6]; Homo sapiens; miRNA-Seq SRP187871 SRS4462709 GSM3660259 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660259 GEO Accession GSM3660259 SRX5492842 GSM3660260 GSM3660260: Patients plasma exosomal miRNA [N7]; Homo sapiens; miRNA-Seq SRP187871 SRS4462710 GSM3660260 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660260 GEO Accession GSM3660260 SRX5492843 GSM3660261 GSM3660261: Patients plasma exosomal miRNA [N8]; Homo sapiens; miRNA-Seq SRP187871 SRS4462711 GSM3660261 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660261 GEO Accession GSM3660261 SRX5492844 GSM3660262 GSM3660262: Patients plasma exosomal miRNA [N9]; Homo sapiens; miRNA-Seq SRP187871 SRS4462712 GSM3660262 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660262 GEO Accession GSM3660262 SRX5492845 GSM3660263 GSM3660263: Patients plasma exosomal miRNA [N10]; Homo sapiens; miRNA-Seq SRP187871 SRS4462713 GSM3660263 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660263 GEO Accession GSM3660263 SRX5492846 GSM3660264 GSM3660264: Patients plasma exosomal miRNA [N11]; Homo sapiens; miRNA-Seq SRP187871 SRS4462714 GSM3660264 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660264 GEO Accession GSM3660264 SRX5492847 GSM3660265 GSM3660265: Patients plasma exosomal miRNA [N12]; Homo sapiens; miRNA-Seq SRP187871 SRS4462715 GSM3660265 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660265 GEO Accession GSM3660265 SRX5492848 GSM3660266 GSM3660266: Patients plasma exosomal miRNA [N13]; Homo sapiens; miRNA-Seq SRP187871 SRS4462716 GSM3660266 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660266 GEO Accession GSM3660266 SRX5492849 GSM3660267 GSM3660267: Patients plasma exosomal miRNA [N14]; Homo sapiens; miRNA-Seq SRP187871 SRS4462717 GSM3660267 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660267 GEO Accession GSM3660267 SRX5492850 GSM3660268 GSM3660268: Patients plasma exosomal miRNA [N15]; Homo sapiens; miRNA-Seq SRP187871 SRS4462718 GSM3660268 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660268 GEO Accession GSM3660268 SRX5492851 GSM3660269 GSM3660269: Control plasma exosomal miRNA [Z1]; Homo sapiens; miRNA-Seq SRP187871 SRS4462719 GSM3660269 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660269 GEO Accession GSM3660269 SRX5492852 GSM3660270 GSM3660270: Control plasma exosomal miRNA [Z2]; Homo sapiens; miRNA-Seq SRP187871 SRS4462720 GSM3660270 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660270 GEO Accession GSM3660270 SRX5492853 GSM3660271 GSM3660271: Control plasma exosomal miRNA [Z3]; Homo sapiens; miRNA-Seq SRP187871 SRS4462721 GSM3660271 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA of plasma exosomes was using Qiazol and RNeasy Minelute spin column following the manufacturer's user guide.RNA concentration was determined using Nanodrop. The content and quality of exosomal RNAs were determined using the 2100 Bioanalyzer instrument. RNA libraries were prepared for sequencing using standard Illumina protocols BGISEQ-500 gds 303660271 GEO Accession GSM3660271